Adma Biologics, Inc. financial data

Symbol
ADMA on Nasdaq
Location
C/O Adma Biologics, Inc., 465 State Route 17, Ramsey, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 618 % +2.64%
Quick Ratio 304 % -17%
Debt-to-equity 37 % -64.4%
Return On Equity 54 % +40.5%
Return On Assets 39.4 % +109%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 238M shares +0.68%
Common Stock, Shares, Outstanding 238M shares +0.83%
Entity Public Float 2.54B USD +219%
Common Stock, Value, Issued 24K USD 0%
Weighted Average Number of Shares Outstanding, Basic 239M shares +1.72%
Weighted Average Number of Shares Outstanding, Diluted 245M shares -0.06%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 489M USD +27.6%
Cost of Revenue 221M USD +13.2%
Research and Development Expense 3.78M USD +102%
Operating Income (Loss) 167M USD +45.4%
Nonoperating Income (Expense) -11.2M USD +72.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 156M USD +112%
Income Tax Expense (Benefit) -53.7M USD -1127%
Net Income (Loss) Attributable to Parent 209M USD +207%
Earnings Per Share, Basic 0 USD/shares +203%
Earnings Per Share, Diluted 0 USD/shares +204%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 61.4M USD -29.2%
Accounts Receivable, after Allowance for Credit Loss, Current 138M USD +175%
Inventory, Net 197M USD +14.5%
Assets, Current 403M USD +26.5%
Deferred Income Tax Assets, Net 74.4M USD
Property, Plant and Equipment, Net 69.5M USD +29.5%
Operating Lease, Right-of-Use Asset 9.27M USD +4.2%
Intangible Assets, Net (Excluding Goodwill) 491K USD +1.24%
Goodwill 3.53M USD 0%
Assets 569M USD +45.6%
Accounts Payable, Current 24M USD +49.9%
Contract with Customer, Liability, Current 143K USD -87.3%
Liabilities, Current 56.5M USD +25.8%
Operating Lease, Liability, Noncurrent 9.4M USD +6%
Other Liabilities, Noncurrent 90K USD -76%
Liabilities 138M USD -13.4%
Retained Earnings (Accumulated Deficit) -211M USD +49.8%
Stockholders' Equity Attributable to Parent 431M USD +85.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 373M USD +143%
Liabilities and Equity 569M USD +45.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.7M USD -787%
Net Cash Provided by (Used in) Financing Activities -7.13M USD -393%
Net Cash Provided by (Used in) Investing Activities -4.72M USD -99.8%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 240M shares +1.39%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -31.5M USD -423%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 61.4M USD -29.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.75M USD +371%
Deferred Tax Assets, Valuation Allowance 0 USD -100%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.23 pure +913%
Deferred Tax Assets, Gross 94M USD -15.1%
Payments to Acquire Property, Plant, and Equipment 4.7M USD +100%
Lessee, Operating Lease, Liability, to be Paid 15.4M USD -0.35%
Property, Plant and Equipment, Gross 95M USD +12%
Operating Lease, Liability, Current 1.3M USD +8.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.56M USD +18.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.58M USD +6.69%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure
Deferred Income Tax Expense (Benefit) 3.43M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.71M USD -12.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.6M USD +27.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.54M USD +21.5%
Operating Lease, Payments 2.4M USD 0%
Additional Paid in Capital 665M USD +2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 120K USD -78.2%
Depreciation, Depletion and Amortization 7.9M USD +3.95%
Deferred Tax Assets, Net of Valuation Allowance 94M USD +913%
Interest Expense 22.7M USD +3.07%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%